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Abstract
Epithelial cells provide an initial line of defense against damage and pathogens in barrier tissues such as the skin; however
this balance is disrupted in obesity and metabolic disease. Skin cd T cells recognize epithelial damage, and release cytokines
and growth factors that facilitate wound repair. We report here that hyperglycemia results in impaired skin cd T cell
proliferation due to altered STAT5 signaling, ultimately resulting in half the number of cd T cells populating the epidermis.
Skin cd T cells that overcome this hyperglycemic state are unresponsive to epithelial cell damage due to chronic
inflammatory mediators, including TNFa. Cytokine and growth factor production at the site of tissue damage was partially
restored by administering neutralizing TNFa antibodies in vivo. Thus, metabolic disease negatively impacts homeostasis and
functionality of skin cd T cells, rendering host defense mechanisms vulnerable to injury and infection.
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Introduction
Resident intraepithelial cd T cells are responsible for
maintaining epithelial integrity, regulating homeostasis and
providing a first line of defense against pathogens and injury in
mice and humans [1,2,3]. cd T cells arise in the thymus during
ontogeny and migrate, in waves, to epithelial tissues such as the
skin, lung, intestine and reproductive tract where they populate
these tissues for the life of the animal [4,5]. In addition to their
role in the innate immune response, cd T cells regulate the
subsequent recruitment of inflammatory cells to sites of injury
and infection [6,7,8]. Murine skin resident T cells express a
canonical Vc3Vd1 T cell receptor (TCR) and respond to a
proposed, yet unknown, self antigen expressed by stressed or
damaged keratinocytes [9,10]. Skin cd T cells display a dendritic
morphology, retract their dendrites following activation and are
critical for epidermal homeostasis and wound repair through
their production of cytokines and regulation of inflammatory cells
[1,6,11,12,13,14,15]. Mice deficient in cd T cells exhibit
disrupted skin homeostasis, impaired barrier function and
delayed wound healing [1,15,16,17]. In humans, the epidermis
consists of a mixed resident ab and cd T cell population [18].
Similar to observations in mice, skin-resident Vd1
+ cd T cells in
humans produce cytokines and growth factors after activation
and participate in wound repair [19].
In obesity and metabolic syndrome, the epidermal barrier is
disrupted and skin complications can ultimately result in chronic
and debilitating non-healing wounds and persistent infections
[20]. Chronic wounds in obese and diabetic patients show
diminished or altered levels of growth factors, impaired leukocyte
infiltration and function and the absence of cell growth and
migration over the wound [20]. Even with medical treatment,
these chronic non-healing wounds may ultimately result in
amputation of extremities [21]. Recent work has focused on the
initiation of chronic inflammation in adipose tissue in obesity. An
increase in effector CD8
+ T cells and a decrease in CD4
+ and T
regulatory cells in adipose tissue have been shown to correlate
with exacerbated adipocyte inflammation and metabolic disease
progression [22,23,24]. However, the consequence of obesity
and metabolic disease on the function of skin resident
lymphocyte populations and how this contributes to skin
complications associated with obesity and metabolic disease are
unknown.
In this study we investigated how skin cd T cell function
becomes altered in obesity and metabolic disease. We show that
the progression of metabolic disease impacts both the homeostasis
and wound healing response of skin cd T cells. Correlating with
early hyperglycemia, the proliferation of skin cd T cells is
impaired, which ultimately results in a reduction in tissue-resident
epidermal T cell numbers. The remaining skin cd T cells
overcome this hyperglycemic state, but exhibit altered metabolic
and nutrient sensing pathways. The chronic inflammatory
environment, specifically elevated TNFa, renders the remaining
skin cd T cells dysfunctional to tissue damage. In this
inflammatory environment, skin cd T cells are unresponsive to
keratinocyte stimulation and unable to produce cytokines and
epithelial regulating factors such as TGFb1. We can improve skin
cd T cells function in vivo by blocking TNFa, providing evidence
that chronic TNFa in metabolic syndrome contributes to skin cd
T cell dysfunction in wound healing.
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Skin cd T cells are unable to maintain epidermal numbers
in obesity
Skin cd T cells arise in the thymus during fetal development,
migrate to the skin and actively expand to reach a maximum of
,5% of the total cells in the epidermis. After this early migration,
the epidermal skin cd T cell compartment is maintained through
self-renewal. To determine the impact of obesity and metabolic
disease on skin cd T cell survival and maintenance, we quantified
cd T cell numbers in epidermal sheets and analyzed their
morphology starting at 6-weeks of age and continuing out to
14-weeks of age. Epidermal sheets from 6-week old db/+ (lean
control) and db/db mice demonstrated that skin cd T cells seeded
the epidermis, were present in expected numbers and exhibited
their characteristic dendritic morphology (Figure 1A). However,
at this 6-week time point, a slight decrease in cd T cell numbers
was observed. By 8- and 10-weeks of age a pronounced decrease in
skin cd T cell numbers was apparent in obese db/db mice
(Figure 1A and 1B). Following this rapid decline, epidermal cd T
cells stabilized at 10-weeks of age and remained reduced out to 14-
weeks of age (Figure 1A and 1B).
In addition to the lymphocyte population, a resident dendritic
cell population, the Langerhans cells (LC), also resides in the skin.
Figure 1. Reduced numbers of skin cd T cells during obesity and metabolic disease is associated with hyperglycemia. (A) cd TCR
immunofluorescence staining of epidermal sheets from BKS db/+ and db/db mice at 6-, 10- and 14-weeks of age. (B) Graphical representation of the
number of epidermal cd T cells in db/+ (solid line) and db/db (dashed line) mice at each age. *p,0.005. (C) Epidermal sheets from 10-week old BKS db/
+ and db/db mice immunostained for the LC marker, langerin. (D) Graphical representation of the number of Langerhans cells at 10-weeks of age. All
microscopy images were acquired at6200. The bar represents 0.05 mm. Data (mean 6 SEM) are representative of three independent experiments for
each age group and a minimum of 15 fields per mouse.
doi:10.1371/journal.pone.0011422.g001
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another skin-resident immune population, we examined LC
numbers using anti-langerin and anti-CD45.2 antibodies to stain
epidermal sheets [25]. Obese db/db mice had similar numbers of
LC in the epidermis as compared to lean db/+ control mice at all
ages tested (Figure 1C and 1D). Our data suggest that the early
progression of obesity and metabolic syndrome are marked by a
selective inability of skin cd T cells to maintain homeostatic
numbers within the epidermis.
To address the possible contribution of leptin receptor
deficiency on skin cd T cells from db/db animals, we investigated
the expression of leptin (Lep) and two leptin receptor isoforms
(Lepr) in skin cd T cells. No expression of either leptin or two
leptin receptor isoforms, Ob-Ra and Ob-Rb, was detected in
mRNA from skin cd T cells isolated directly ex vivo or in the cd 7–
17 cell line in vivo (Figure S1).
Hyperglycemia alters STAT5 signaling and impedes cd T
cell proliferation
Between 6- and 10-weeks of age, BKS db/db mice are
hyperglycemic and exhibit greater weight gain than their db/+
control littermates (Table S1). To determine the impact of
environmental factors that are present during this phase of disease,
such as glucose and fatty acids, we tested whether the 7–17 skin cd
T cell line can maintain itself and survive when these factors are
present and elevated. We found that 7–17 cd T cells treated with
33.3 mM glucose resulted in a rapid decline of T cells within 24 to
48 hours of treatment (Figure 2A). However, treatment of 7–17
cd T cells with fatty acids did not inhibit cd T cell growth (Figure
S2).
To investigate the impact of glucose on skin cd T cell
proliferation, 7–17 cells were maintained in IL-2, treated with
elevated glucose and proliferation determined. As shown in
Figure 2B, there was a dose dependent inhibition of cd T cell
proliferation 36 hours post-glucose treatment. In addition to the
7–17 cd T cell line, freshly isolated skin cd T cells were sorted
from epidermal cell preparations from wild-type mice, placed into
IL-2 containing media in the presence of baseline (11.2 mM) or
elevated (33.3 mM) glucose. Similar to observations with the 7–17
cd T cell line, freshly isolated skin cd T cells also displayed
reduced proliferation in the presence of elevated glucose
(Figure 2C). This data suggests that skin cd T cells are highly
sensitive to elevations in glucose, affecting their ability to
proliferate and maintain homeostatic numbers.
Since cd T cells proliferate after stimulation with IL-2 in a
glucose-sensitive manner, we next asked whether glucose treat-
ment alters downstream IL-2 signaling. IL-2 receptor binding
results in Jak1 and Jak3 activation, phosphorylation of STAT5 and
translocation of the STAT5 complex to the nucleus where it
regulates gene transcription [26]. Following stimulation of
untreated skin cd T cells with IL-2, phosphorylation of STAT5A
and STAT5B peaked at 30 minutes, followed by a rapid decrease
in phosphorylation (Figure 2D). However, in glucose-treated cd
T cells, STAT5A was rapidly phosphorylated to peak levels within
10 to 30 minutes after IL-2 stimulation but displayed altered
kinetics and prolonged phosphorylation compared to untreated
cells. In addition, glucose-treated cd T cells had negligible
phosphorylation of STAT5B after IL-2 stimulation (Figure 2D).
This data suggests that diminished proliferation of skin cd T cells
may be due to altered IL-2 and STAT5 signaling in response to
hyperglycemic conditions. Moreover, STAT5A/B signaling is
critical to cd T cell function as cd T cells are absent in mice
deficient in STAT5A/B [27].
To determine if diminished skin cd T cell proliferation in BKS
db/db mice accounts for the reduction in epidermal T cell
numbers, we first had to investigate the rate of cd T cell
proliferation in vivo. Although long-lived, memory-like Vc2
+ T cells
in the periphery have been shown to have very slow turnover [28],
the rate of Vc3
+ T cell proliferation and homeostatic maintenance
in the epidermis has yet to be defined. Unlike the rapid turnover of
epithelial keratinocytes [29,30,31], LC turnover is much slower,
between 5 and 10% of cells proliferating per week [32,33]. To
determine the rate of cd T cell proliferation in the epidermis,
control BKS db/+ mice were treated for one week with BrdU in
the drinking water and skin cd T cells were analyzed for BrdU
incorporation at 6- and 10-weeks of age. Skin cd T cell
proliferation in 6- and 10-week old lean db/+ mice averaged
approximately 11% of the total cells proliferating per week
(Figure 2E, left panels).
BrdU incorporation was then quantified in 6- and 10-week old
BKS db/db mice to ascertain whether decreased proliferation
accounts for diminished skin cd T cell numbers in the db/db
mouse. In contrast to the 10–12% BrdU incorporation of skin cd
T cells in 6-week old lean db/+ mice, only half as many cd T cells
incorporated BrdU in db/db mice (Figure 2E, right panel, and
2F). This reduced percentage of cd T cells isolated from 6-week
old db/db mice indicates decreased skin cd T cell turnover in the
BKS db/db mouse. Turnover of epithelial keratinocytes confirmed
that BrdU was reaching the skin and being incorporated at a
similar rate in 6-week old BKS db/+ and db/db (Figure 2G). In
contrast to 6-week old mice, skin cd T cells from obese 10-week
old db/db mice had a similar percentage of skin cd T cells
incorporating BrdU as compared to control db/+ mice
(Figure 2E, right panel, and 2F). This correlates with the
data presented in Figure 1B, which shows that cd T cell numbers
stabilize in 10-week old db/db mice.
To confirm that skin cd T cells were not undergoing increased
apoptosis in BKS db/db mice, freshly isolated cd T cells from the
epidermis were stained with annexin-V and subject to propidium
iodide incorporation (PI). No significant changes in skin cd T cell
annexin
+PI
+ populations were detected between lean db/+ and
obese db/db animals at multiple ages (Figure S3A). Furthermore,
to verify that skin cd T cells in the obese environment were not
migrating out of the epidermis, whole skin cross-sections were
stained with cd TCR-specific antibodies and analyzed by
immunofluorescent microscopy. We established that cd T cells
in the BKS db/db mouse remained localized to the epidermis and
hair follicles (Figure S3B) and were not found migrating into the
dermis. Additionally, skin-specific Vc3
+ T cells were not detected
in lymph nodes providing further evidence that they have not
migrated out of the epidermis (Figure S3C).
Taken together, this data demonstrates that hyperglycemia
impacts skin cd T cell proliferation, specifically at 6-weeks of age,
ultimately reducing the population of skin cd T cells in the
epidermis by half. However, by 10-weeks of age, the remaining
skin cd T cells in the db/db animals have overcome the impaired
proliferation induced by hyperglycemia.
Skin cd T cells are unresponsive to tissue damage in
obesity
Since a population of skin cd T cells survived the hyperglycemic
environment, we next asked whether the remaining skin cd T cells
in the 10-week old db/db mice were able to respond to epithelial
damage in vivo. One major function of skin cd T cells is to
recognize epithelial tissue damage and release cytokines and
growth factors that facilitate wound repair. To investigate whether
the remaining skin cd T cells in the obese mouse are able to
Skin cd T Cells in Obesity
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cd T cells to retract their dendrites at the wound edge. Following
injury and activation through their TCR, cd T cells round-up at
the wound edge and lose their dendritic morphology [1]. Cells
distal to the wound site remain dendritic [1], confirming that this is
a localized response to tissue damage. Full-thickness punch biopsy
wounds were performed on obese 10- to 14-week old BKS db/db
mice and skin cd T cell morphology was examined at various time
points by immunofluorescent microscopy. Our data indicates that
skin cd T cells in the obese db/db mice were delayed in their ability
to round following wounding as compared to lean db/+ control
mice (Figure 3A). These results were confirmed by quantifying
the number of cd T cells having retracted all their dendrites
(Figure 3B).
Another characteristic feature of skin cd T cell activation is the
upregulation of several Th1-type proinflammatory cytokines,
including TNFa [34]. To determine if skin cd T cells in obese
mice have lost their ability to produce cytokines, we examined
TNFa production by cd T cells located along the wound edge.
Full-thickness punch biopsy wounds were performed, cd T cells
were isolated from the wound edge, treated with brefeldin A and
immediately stained using intracellular cytokine staining. This
technique allows for the examination of skin cd T cell function
immediately ex vivo without any additional stimulus beyond the
wound. In wild-type mice, cytokine production (using TNFa as a
readout) was upregulated in skin cd T cells directly adjacent to the
wound site in control BKS db/+ mice (Figure 3C). However, cd
T cells isolated from the wounds of obese 10- to 14-week old BKS
db/db mice did not produce TNFa (Figure 3C).
We confirmed our in vivo wound healing results in another
mouse model of obesity, the diet-induced obesity (DIO) model.
C57BL/6J mice were started on a 60% kcal fat diet (B6 HFD) at 6
weeks of age compared to the normal chow diet (B6 NCD) (Table
S1). As shown in Figure 3D, cd T cells isolated from B6 NCD
mice upregulated TNFa production at the wound edge compared
to non-wounded controls. However, similar to BKS db/db animals,
skin cd T cells isolated from 26- to 32-week old B6 HFD mice had
little upregulation of TNFa at the wound edge (Figure 3D).
In addition to early release of proinflammatory molecules,
growth factor production is another key function of skin cd T cells
in response to epithelial damage. We therefore reasoned that this
functional response of skin cd T cells was likely to be disrupted in
skin cd T cells in the obese environment. To address this directly,
we investigated intracellular TGFb1 production in skin cd T cells
isolated from wounded lean control and obese animals. Skin cd T
cells from control 10- to 14-week old BKS db/+ animals increased
TGFb1 production at the wound edge 24 hours post-wounding
(Figure 3E). However, skin cd T cells from obese 10- to 14-week
old db/db mice had little to no upregulation in TGFb1 expression
(Figure 3E). This defective TGFb1 production was confirmed in
our second model of obesity, the DIO model. Skin cd T cells
isolated from the wound edge of B6 NCD mice upregulated
TGFb1 production, however, skin cd T cells isolated from the
wound edge of 26- to 32-week old B6 HFD mice had impaired
TGFb1 upregulation (Figure 3F). Therefore, in addition to
defective cytokine production, skin cd T cells in obesity and
metabolic disease were unable to upregulate TGFb1 production at
the wound edge, an important growth factor in several aspects of
wound repair.
Delayed rounding and the inability of skin cd T cells to produce
cytokines at the wound edge only occurred in obese 10- to 14-week
old db/db animals. Skin cd T cells in 6-week old db/+ and db/db
mice retracted their dendrites similarly within 4 hours post
wounding and were able to upregulate TNFa adjacent to the
wound edge (data not shown). Together, this data suggests two
separate stages of disease: 1) an early defect in skin cd T cell
proliferation due to hyperglycemia that eventually results in half
the number of skin cd T cells residing in the epidermis and 2) a
later defect characterized by the inability of skin cd T cells to
perform tissue repair functions in vivo.
Impaired skin cd T cell nutrient sensing and activation in
obesity
The inability of skin cd T cells to be activated and produce
cytokines and growth factors following epithelial damage occurred
only in 10- to 14-week old BKS db/db and not 6-week old mice.
This unresponsive state was not caused by hyperglycemia and
suggests that other environmental factors, such as chronic
inflammatory factors, or cell-intrinsic factors may be responsible
for the lack of tissue damage responses. To better understand the
impact of metabolic disease on skin cd T cells, we performed
microarray analysis on skin cd T cells sorted from total epidermal
cell preparations from 10-week old BKS lean db/+ and obese db/
db mice.
Based on the gene array, we found that skin cd T cells
differentially express NR4A1 and NR4A3, two orphan nuclear
receptors which have been shown to sensitize muscle to insulin and
have been reported to be underexpressed in obesity and type 2
diabetes [35]. We observed reduced expression of both NR4A1
and NR4A3 in cd T cells isolated from obese db/db mice
(Figure 4A), suggesting that skin cd T cells residing in db/db
animals have decreased insulin sensitivity. Additionally, Pdk1, a
central molecule that regulates Akt function, and two members of
the mTORC2 complex, Rictor and Sin 1 (Mapkap1), all display
decreased gene expression in skin cd T cells isolated from obese
db/db mice (Figure 4B). Together these genes, which are
necessary for the growth and function of cd T cells [36], were
altered in obese mice and reveal a breakdown in the normal
signaling pathways required for skin cd T cells homeostasis and
function.
Figure 2. Regulation of skin cd T cell proliferation by glucose is associated with decreased STAT5B phosphorylation. (A) In vitro
growth of cd 7–17 T cell line treated with 33.3 mM glucose at 0, 24 and 48 hours. Data (mean 6 SD) presented as the % of glucose treated cells to
untreated control cells. (B, C) Proliferation of (B) cd 7–17 T cells and (C) freshly isolated cd T cells sorted from wild-type B6 mice in IL-2 containing
growth media supplemented with elevated glucose concentrations. Each experiment was performed in triplicate, data presented as mean 6 SD. (D)
The kinetics of expression of phosphorylated STAT5A and STAT5B following 40U/ml IL-2 stimulation in untreated and glucose treated cd 7–17 T cells.
Total STAT5 expression demonstrates even loading and expression. (E) Multiparameter flow cytometry of BrdU incorporation by skin cd T cells
isolated from 6- and 10-week old BKS db/+ and db/db mice treated with BrdU for 7 days. The same number of events is presented for each dot plot,
numbers indicate the percent of cd T cells that have incorporated BrdU. Epidermal cells were gated on live Thy1.2
+ events for cd T cells. (F) Graphical
representation of the ratio of BrdU incorporation by cd T cells in BKS db/+ to db/db mice at 6-weeks and 10-weeks of age, n=3per strain and age.
Shown are black dots to represent the ratio of each experiment, the black line represents the average of three experiments. (G) Multiparameter flow
cytometry of BrdU incorporation by keratinocytes isolated from 6-week old BKS db/+ and db/db mice treated with BrdU for 7 days. The same number
of events is presented for each dot plot, numbers on the right indicate the percent of keratinocytes that have incorporated BrdU. Epidermal cells
were gated on live cd TCR
2 events for keratinocytes. Data are representative of five (A, B) or three (C–G) separate experiments.
doi:10.1371/journal.pone.0011422.g002
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changes to their characteristic innate T cell phenotype and
function. Skin cd T cells express a Vc3Vd1 TCR and
constitutively elevated levels of the activation markers CD69 and
CD25 (IL-2 receptor a), suggesting that they are primed to rapidly
respond to TCR-mediated activation and growth factors, such as
IL-2 [1,36,37]. No changes were observed in the expression of
activation markers on skin cd T cells isolated from 6-week old
BKS db/+ and db/db mice (Figure S4A). However, in obese db/db
mice at 10-weeks of age, skin cd T cells reproducibly displayed
diminished levels of CD69, CD25 and CD103 (Figure 4C).
Furthermore, cd TCR expression was reproducibly decreased in
10-week old obese db/db mice (Figure 4D), but no decrease in cd
TCR expression was observed in 6-week old db/db mice (Figure
S4B). Decreased expression of activation markers and cd TCR
may be due to overstimulation by stressed keratinocytes in obesity
and metabolic disease.
cd TCR does not contribute to epidermal T cell
dysfunction in obesity
To investigate the contribution of the cd TCR to the
hyporesponsive state of skin cd T cells in obesity, we crossed B6
d
2/2 and B6 db/+ animals to generate mice lacking cd TCR that
develop obesity and metabolic disease (Figure 5A). The epidermis
of cd T cell knockout mice (d
2/2) lacks Vc3
+ T cells but does have
an ab T cell population that takes up residence, however, these ab
T cells do not respond to keratinocyte damage [37]. No differences
in breeding, litter size or growth of the animals were observed in
the B6 d
2/2 db/db mice as compared to B6 db/db animals. Both
male and female B6 d
2/2 db/db mice gained weight and became
obese similar to B6 db/db mice (Figure 5B).
To determine the impact of the cd TCR on maintenance of
homeostatic numbers of epidermal T cells in d
2/2 db/db animals,
epidermal ab T cells were visualized using immunofluorescent
microscopy. In both d
2/2 db/+ control and d
2/2 db/db mice, the
only T cell population in the epidermis was CD3
+ ab T cells; no
cd T cells or other CD3
+ populations were present, similar to the
epidermal T cell makeup of B6 d
2/2 mice (data not shown).
However, in 14-week old obese d
2/2 db/db mice there were
,30% fewer epidermal ab T cells compared with lean d
2/2 db/+
control animals (Figure 5C). This suggests that the keratinocyte
antigen-specific cd TCR is not necessary for the decline in
epidermal T cell numbers observed in obesity.
Although the epidermal ab T cells identified in B6 d
2/2 mice
are not responsive to keratinocyte damage, they do express the
activation markers CD69, CD25 and CD103 similar to cd T cells
in the skin [37]. Since expression of these molecules was
diminished on cd T cells in the obese environment, we determined
whether activation markers on epidermal ab T cells in the B6
d
2/2 db/db mouse were similarly affected. Decreased expression of
both CD69 (Figure 5D) and CD25 (data not shown) was
observed on epidermal ab T cells in 14-week old obese B6 d
2/2
db/db mouse similar to that observed on epidermal cd T cells in
obese B6 db/db mice. Together, this data suggests that the
hyporesponsiveness observed in cd T cells of obese mice is not
TCR mediated or a direct consequence of overactivation by
stressed keratinocytes. Therefore, dysfunction of skin cd T cells in
obesity and metabolic disease may be a direct consequence of the
inflammatory milieu of the obese environment.
Rescue of skin cd T cell function ex vivo
If the environment in obesity and metabolic disease contributes
to skin cd T cell dysfunction, we hypothesized that removal from
this environment would improve skin cd T cell function. To
investigate whether the response of skin cd T cells in obese mice
can be restored by removal from their environment, we isolated
epidermal sheets from 10- to 14-week old obese BKS db/db mice
and lean db/+ controls and stimulated the skin-resident T cells in
vitro with anti-CD3e antibody. After 6 hours in culture, we
visualized epidermal sheets by immunofluorescent microscopy and
quantified the number of dendrites per cell to determine cellular
rounding after stimulation. The majority of cd T cells in
unstimulated epidermal sheets exhibited 3 or more dendrites per
cell (Figure 6A). However, after anti-CD3e stimulation, cd T cells
began to round up similarly in epidermal sheets isolated from
obese db/db and control db/+ mice, as indicated by the reduced
number of skin cd T cells with 3 or more dendrites per cell
(Figure 6A and 6B). This indicates that removing epidermal cells
from the obese db/db mouse, where they were unable to round
upon wounding, restores the ability of cd T cells to respond to
stimulation.
Since stimulating epidermal sheets from obese db/db mice ex vivo
restored the ability of skin cd T cells to round, we next identified
whether other cd T cell functions could be rescued as well. To
determine if cytokine production could be restored by removing
cd T cells from the obese environment, we isolated epidermal cells
from 10- to 14-week old BKS lean db/+ and obese db/db mice and
cultured them in plates either coated with PBS (unstimulated) or
anti-CD3e antibody. Strikingly, upon removal from the obese
environment, anti-CD3e stimulated skin cd T cells from obese db/
db mice were able to produce cytokines, such as TNFa, and
upregulate the activation marker CD25 to a similar degree as skin
cd T cells isolated from control db/+ animals (Figure 6C).
Together, these data demonstrate that the dysfunction of skin cd T
cells in the obese db/db mouse is not permanent. It suggests that by
removing extrinsic factors present in obesity and metabolic disease
through the isolation of these cells from the epidermis, the
hyporesponsive state of skin cd T cells can be reversed.
Blocking TNFa in obese mice restores skin cd T cell
function in epithelial repair
Increased plasma TNFa levels correlate with obesity and insulin
resistance in both humans and animals [38]. Our microarray data
revealed that several members of the TNFa signaling pathway
were increased in skin cd T cells isolated from obese db/db mice,
including Traf2, Tradd and Ripk1 (Figure 7A), which lead to
activation of NF-kB and Jun N-terminal kinase (JNK) [39]. As
Figure 3. Obese mice display impaired skin cd T cell wound healing functions after injury. (A) Immunofluorescent staining for cd TCR in 12-
week oldlean BKSdb/+andobesedb/dbmicefour hourspost-wounding.ThewhitedashedlinerepresentsthewoundedgeandarrowheadsdepictcdT
cells that have rounded near the wound edge. A minimum of 10 images was acquired at the wound edge for each experiment and the number of
dendrites was determined per cell, a minimum of 300 total cells were counted. (B) Shown is the percentage of cd T cells with 0 dendrites per cell (mean
6 SEM). All images were acquired at6200 magnification. (C, D) Skin cd T cell production of TNFa in non-wounded and wounded skin tissue of (C)1 2 -
week old BKS db/+ and db/db mice and (D) 27-week old B6 NCD and HFD mice. The numbers represent the percentage of cells expressing TNFa. Skin cd
T cell production of TGFb1 in non-wounded and wounded skin tissue of (E) 12-week old BKS db/+ and db/db mice and (F) 27-week old B6 NCD and HFD
mice. The numbers represent the percentage of cells expressing TGFb1. Epidermal cells were gated on live Thy1.2
+ and cd TCR
+ to distinguish cd T cells.
Shown is one representative experiment, a minimum of three experiments were performed with similar results (A–F).
doi:10.1371/journal.pone.0011422.g003
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PLoS ONE | www.plosone.org 8 July 2010 | Volume 5 | Issue 7 | e11422Figure 4. Impaired activation and nutrient sensing by skin cd T cells in obese mice. (A, B) Microarray analysis of skin cd T cells isolated
from 10-week old BKS db/+ and db/db mice. Shown is gene expression of molecules associated with (A) insulin sensitivity and (B) PI3K/Akt/mTOR
signaling. Data is presented as the mean of two independent experiments 6 SEM. (C) Multiparameter flow cytometry of CD69, CD25 and CD103 on
the cell surface of cd T cells isolated from BKS db/+ and db/db in mice at 10-weeks of age. Numbers in the top right corners indicate percent of cd T
cells. (D) cd TCR expression on cd T cells isolated from BKS db/+ (solid line) and db/db (shaded gray) at 10-weeks of age. Dotted lines represent
unstained controls. Epidermal cells were gated on live Thy1.2
+ to distinguish cd T cells. A minimum of three experiments were performed per age,
shown is one representative experiment for each, the same number of events is presented for each dot plot.
doi:10.1371/journal.pone.0011422.g004
Figure 5. cd TCR does not contribute to defective skin cd T cells in obese mice. (A) d
2/2 db/db mice were generated by breeding C57BL/6J
d
2/2 mice with C57BL/6J db/+ mice. (B) Weight of d
2/2 db/db and B6 db/db obese mice compared to their d
2/2 db/+ and B6 db/+ lean littermates.
Data is presented as the mean weight 6 SD. Between two and eleven mice were weighed per age per strain. (C) Graphical representation of the
number of epidermal T cells at 14-weeks of age. Skin cd T cells were counted in epidermal ear sheets from three d
2/2 db/+ mice and four d
2/2 db/db
mice. The mean was determined for each experiment (black dots) and the black line represents the average of all the experiments. A minimum of 15
fields were counted for each mouse per experiment, with a minimum of 500 cells per experiment, a minimum of three independent experiments
were performed. (D) Multiparameter flow cytometry of CD69 expression on the cell surface of cd T cells isolated from B6 db/+ and db/db and d
2/2
db/+ and db/db mice at 14-weeks of age. Numbers on the top right corner indicate percent of ab T cells. Epidermal cells were gated on live CD3
+ and
Thy1.2
+ to distinguish epidermal T cells. A minimum of three experiments were performed, shown is one representative experiment, the same
number of events is presented for each dot plot.
doi:10.1371/journal.pone.0011422.g005
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PLoS ONE | www.plosone.org 9 July 2010 | Volume 5 | Issue 7 | e11422Figure 6. The obese environment inhibits skin cd T cell function. (A) Skin cd T cell morphology changes in epidermal sheets isolated from 10-
to 14-week old BKS db/+ and db/db following in vitro stimulation with 10 mg/ml anti-CD3e antibody compared to unstimulated control. All
microscopy images were acquired at 6200 and the bar represents 0.05 mm. (B) Shown is a graphical representation of the percentage of skin cd T
cells with 0, 1, 2 or $3 dendrites, which represent the degree of cd T cell rounding (mean 6 SEM), in epidermal ear sheets from 10- to 14-week old
BKS db/+ and obese db/db animals stimulated with 10 mg/ml anti-CD3e antibody. Three independent experiments were performed, a minimum of 10
fields were counted for each, and this data represents the average of all 35 fields and approximately 1000 total cells. (C) Multiparameter flow
cytometry of TNFa production and CD25 expression by cd T cells isolated from 10- to 14-week old BKS db/+ and db/db mice following overnight
stimulation with 1 mg/ml anti-CD3e. Numbers in the upper right corner indicate percent cd T cells. Epidermal cells gated on live Thy1.2
+ events. Data
are representative of at least three independent experiments.
doi:10.1371/journal.pone.0011422.g006
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PLoS ONE | www.plosone.org 10 July 2010 | Volume 5 | Issue 7 | e11422Figure 7. Neutralization of TNFa rescues skin cd T cell function at the wound site. (A, B) Microarray analysis of skin cd T cells isolated from
10-week old BKS db/+ and obese db/db mice. Shown is gene expression of molecules associated with TNFa signaling. Data is presented as the mean
of two independent experiments 6 SEM. (C) Epidermal sheets isolated from 10- to 14-week old BKS db/+ and obese db/db animals either
unstimulated or stimulated with 10 mg/ml anti-CD3e antibody and 100 ng/ml TNFa. All microscopy images were acquired at 6200 and the bar
represents 0.05 mm. (D) Quantification of the percentage of skin cd T cells with 0, 1, 2 or $3 dendrites, which represent the degree of cd T cell
rounding (mean 6 SEM), in epidermal ear sheets from 10- to 14-week old BKS db/+ and obese db/db animals stimulated with 10 mg/ml anti-CD3e
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survival, such as Birc5 (survivin), are increased in skin cd T cells
isolated from obese db/db animals. However, molecules that
negatively regulate Ripk1 and Jnk signaling, such as Tnfaip3 (A20)
and GADD45b respectively [40], are decreased in cd T cells
isolated from obese db/db mice.
Since elevated gene expression of TNFa signaling molecules
was observed in skin cd T cells isolated from obese db/db mice, we
set out to determine the consequence of elevated and chronic
TNFa levels on skin cd T cell function. Exogenous TNFa was
added to cultured epidermal sheets isolated from control and
obese animals. If TNFa alone contributes to the suppressive
inflammatory milieu, skin cd T cells would remain impaired upon
ex vivo stimulation in the presence of this cytokine. Epidermal
sheets from 10- to 14-week old lean db/+ mice, which have not
been exposed to chronic TNFa in their environment, rounded
when stimulated with anti-CD3e antibody in the presence of acute
TNFa (Figure 7C and 7D). However, cd T cells in epidermal
sheets isolated from obese db/db animals, which have been
exposed to elevated and chronic TNFa in their environment,
displayed delayed rounding when stimulated with anti-CD3e
antibody only if TNFa was present (Figure 7C and 7D). As
shown in Figure 6A, epidermal sheets from obese db/db mice
were able to round following stimulation with anti-CD3e antibody
alone. This suggests that TNFa alone alters the ability of skin cd T
cells to round following stimulation, providing a mechanism for
skin cd T cell dysfunction.
Due to the contribution of chronic TNFa to cd T cell
dysfunction, we investigated whether skin cd T cell responses to
tissue damage could be restored in vivo by treatment with
neutralizing anti-TNFa antibody. 10- to 14-week old obese db/
db animals were treated daily for a minimum of four days with
1 mg/kg anti-TNFa or IgG control antibody. On day 4, full-
thickness punch biopsy wounds were performed on each animal
and epidermal cells were isolated around the wound edge 24 hours
post-wounding. Skin cd T cells isolated from obese db/db animals
treated with anti-TNFa antibody showed improved TGFb1
production as compared to db/db animals treated with IgG control
antibody (Figure 7E). Similar rescue of TNFa production was
observed in skin cd T cells isolated from db/db animals treated
with anti-TNFa (Figure 7F). A significant improvement in skin
cd T cell function at the wound site suggests that chronic
inflammatory conditions, specifically in the form of TNFa,
contributes to skin cd T cell hyporesponsiveness to in vivo
wounding in obesity and metabolic disease.
Discussion
Skin cd T cells contribute to homeostatic maintenance of the
epidermis and respond early to epithelial damage. Skin compli-
cations associated with obesity, metabolic disease and type 2
diabetes include barrier dysfunction, chronic non-healing wounds
and increased infection. Due to their role in epidermal homeostasis
and early response to keratinocyte damage, we investigated
whether skin cd T cell are functional in mouse models of obesity
and metabolic disease. Strikingly, we observed a biphasic
progression of epidermal T cell dysfunction and the parameters
responsible for each phase of T cell dysfunction were distinct.
Hyperglycemia impacted early skin cd T cell proliferation and
homeostasis, ultimately resulting in reduced epidermal T cell
numbers. Chronic inflammation, occurring later in metabolic
disease, rendered skin cd T cells hyporesponsive to in vivo
stimulation. In spite of this, skin cd T cell dysfunction was
reversible as improved cytokine production to in vivo stimulation
was restored by systemic anti-TNFa antibody treatment. To our
knowledge, this is the first description correlating different stages of
lymphocyte dysfunction to disease progression in obesity.
Nutrients, such as glucose, are critical for lymphocyte survival,
proliferation, differentiation and function [41,42]. Many growth
factors, such as insulin, IGF-1 and members of the common cc
cytokine family (IL-2, IL-4, IL-7, IL-15) increase glucose uptake
and metabolism via signaling through the PI3K/Akt pathway
[42]. For example, IL-7 signaling in lymphocytes results in STAT5
and PI3K/Akt activation-induced glucose uptake [43]. However,
we report here that during the first phase of dysfunction, skin cd T
cells are highly susceptible to alterations in glucose concentrations.
Similarly, both ab T cells and B cells have been shown to exhibit
reduced proliferation when exposed to elevated glucose concen-
trations in vitro [43]. This suggests that although glucose and other
nutrients may be critical for lymphocyte homeostasis and function,
a chronic overabundance of nutrients is detrimental to the
maintenance of cd T cells in the epidermis.
Elevated glucose resulted in altered STAT5 phosphorylation
after IL-2 stimulation in vitro and ultimately impaired cd T cell
proliferation. STAT5A/B signaling is critical to cd T cells as mice
deficient in STAT5A/B lack cd T cells [27]. The inability of
glucose-treated cd T cells to phosphorylate STAT5B in response
to IL-2 points directly to an effect on proliferation as mice
expressing a constitutively active STAT5B have an expanded cd T
cell population [44]. Additionally, the severity of loss of skin cd T
cells in BKS db/db mice correlates with a period of rapid
expansion of cd T cells in the epidermis at 6-weeks of age. The
hyperglycemic conditions during this seeding are severe in BKS
db/db mice which may explain the sharp decrease in cd T cells.
Overall, these data demonstrate that skin cd T cells are highly
sensitive to metabolic changes, such as hyperglycemia, in the
cellular environment and respond to this stress by shutting down
nutrient sensing pathways, such as cytokine and growth factor
signal reception, resulting in decreased homeostatic proliferation
and a reduced epidermal T cell compartment.
In the next phase of metabolic disease, skin cd T cells become
unresponsive to tissue damage, resulting in reduced production of
skin cd T cell cytokines and growth factors. Skin cd T cells are
important mediators of inflammation and tissue repair as mice
deficient in cd T cells (d
2/2 mice) exhibit delayed wound healing
[1]. Additionally, skin-resident T cells in chronic wounds isolated
from human patients do not upregulate growth factor production,
which may contribute to the inability of chronic non-healing
wounds to resolve [19]. In addition to the production of cytokines
by skin cd T cells early in tissue damage, skin cd T cells also
produce growth factors which are critical to skin homeostasis [16].
We observed a decrease in homeostatic TGFb1 production by skin
cd T cells and an inability to upregulate TGFb1 following injury
in obesity and metabolic disease. In the skin, the effects of TGFb1
antibody and 100 ng/ml TNFa. Three independent experiments were performed, a minimum of 10 fields were counted for each, and this data
represents the average of all 35 fields and approximately 1000 total cells. (E, F) Fold change in MFI of (E) TGFb1 and (F) TNFa expression in skin cd T
cells isolated from the wound edge compared to non-wound edge cells. Skin cd T cells from 10- to 14-week old BKS db/+ mice were used as a positive
control, 10- to 14-week old db/db mice were either treated with 1 mg/kg IgG control antibody or anti-TNFa antibody for a minimum of four days.
Shown in fold change in MFI for 3 separate experiments, significance was determined by t-test.
doi:10.1371/journal.pone.0011422.g007
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including inflammation, angiogenesis, tissue remodeling and
reepithelialization [45]. Altered TGFb1 production by skin cd T
cells in obesity and metabolic disease may impact multiple phases
of epidermal homeostasis and early and late stages of tissue repair.
To understand how the environment impacts the ability of skin
cd T cells to respond to in vivo damage, we performed microarray
analysis to investigate alterations in gene expression and found an
increase in expression of molecules involved in TNFa signaling. In
primary cells, TNFa induces NF-kB but not cell death pathways,
and chronic TNFa would predictably result in chronic NF-kB
activation, gene expression and survival [39]. This persistent
activation leads to the induction of reactive oxygen species [39],
which can attenuate T cell responses [46,47], and uncouple TCR
signal transduction, resulting in lower cell surface expression of the
TCR/CD3 complex [48]. This supports our observation that cell
surface cd TCR expression is decreased and downstream
molecules regulating survival and negative feedback of NF-kB
signaling were altered in skin cd T cells isolated from obese mice.
In addition, chronic TNFa and persistent NF-kB activation
negatively impact other cell signaling pathways, including PI3K/
Akt/mTOR signaling [36,49,50]. TNFa and NF-kB suppress
TSC1 inhibition of mTORC1, resulting in hyperactive mTORC1
activity, which contributes to insulin resistance [50]. Recently,
mTORC1 has been shown to negatively inhibit mTORC2
signaling, a necessary complex for Akt activation, and may
negatively inhibit growth factor signaling in pathways that don’t
require IRS-1 [51]. Furthermore, knockdown or deletion of
mTORC2 complex molecules, including Rictor, Sin1 and Gbl,
result in defective mTORC2 complex assembly and Akt activation
[52,53,54]. Both mTORC1 and mTORC2 have been shown to
be critical for skin cd T cell homeostasis and in vivo wound healing
response [36]. Chronic TNFa stimulation of skin cd T cells results
in direct effects, including alterations in TCR expression, and
effects on other signaling pathways, including mTOR and Akt.
These alterations in signaling ultimately render epidermal T cells
hyporesponsive to barrier tissue disruption and keratinocyte
damage.
Together, our data demonstrate that obesity and metabolic
disease negatively impact the homeostasis and wound healing
functions of cd T cells located in the epidermal barrier. The
impact of chronic TNFa on cd T cells was reversible, suggesting
that therapeutic strategies targeting the inflammatory environment
and cd T cell dysfunction may provide additional treatments for
complications associated with obesity, metabolic disease and type
2 diabetes. In addition to the skin, intraepithelial cd T cells reside
in multiple barrier tissue locations, including the lung and
intestinal tract, and the impact of metabolic disease on the
function of other resident cd T cell populations is unknown. The
consequence of reduced numbers and unresponsiveness of cd T
cells in multiple barrier tissues would result in compromised ability
to protect against damage or environmental insults and increased
susceptibility to infection. This study demonstrates a previously
unrecognized biphasic progression of skin cd T cell dysfunction in
obesity and metabolic disease, in which hyperglycemia impacts
skin cd T cell proliferation and homeostasis and chronic
inflammatory mediators alter skin cd T cell response to barrier
damage.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies. All animal work was approved by The Scripps
Research Institute Institutional Animal Care and Use Committee
(protocol 08-0057).
Mice
Wild-type C57BLKS/J, BKS-Lepr
db heterozygous (C57BLKS/J
db/+), and B6- Lepr
db heterozygous (C57BL/6J db/+) mice were
purchased from The Jackson Laboratory (Bar Harbor) and were
housed and bred at The Scripps Research Institute (TSRI). Wild-
type C57BL/6J mice were bred at TSRI Rodent Breeding
Colony. For high fat diet experiments, wild-type male C57BL/6J
mice were placed on a 60 kcal% fat diet (Research Diets) at 6
weeks of age, control mice were maintained on a 5 kcal% (Harlan
Laboratory) or a 10 kcal% (Research Diets) diet. To generate
d
2/2 db/db mice, C57BL/6J d
2/2 were crossed with C57BL/6J
db/+ mice to generate d
2/2 db/+ mice. All mice were periodically
weighed and blood glucose monitored by an Ascensia Elite XL
blood glucose monitor (Bayer). BKS db/+ and db/db mice were
assayed at 6 weeks and at 10- and 14-weeks of age. For HFD
experiments, mice were assayed after 20 to 26 weeks on HFD.
Mice were given access to food and water ad libitum and were
housed in sanitized conditions.
Flow cytometry
FITC-, PE-, or allophycocyanin-conjugated monoclonal anti-
bodies specific for cd TCR (GL3), Vc3
+ (536), CD25 (PC61),
TNFa (MP6-XT22), CD45.2, IL-4Ra and Thy1.2 (53.2.1) were
purchased from BD Biosciences, CD69 (H1.2F3), CD103, CD3e,
and Langerin antibodies were purchased from eBioscience, and
TGFb1 was purchased from R&D Systems. The BD Bioscience
Cytofix/Cytoperm kit was used for intracellular staining and
Annexin-V/PI kit for flow cytometry. Cells were acquired with
DiVa 5.0 software on a Digital LSRII (BD Biosciences) and
analyzed with FlowJo software (Tree Star, Inc.). For FACS plots,
gating was determined for each individual experiment using
negative or isotype controls.
In vitro cd 7–17 cell line
The skin cd T-cell line 7–17 was maintained in complete RPMI
(Mediatech, Inc.) supplemented with 10% heat-inactivated FBS
and 20U/ml IL-2. For proliferation studies, 7–17 cells were plated
at 1610
5 cells per well in a 96 well flat bottom plate in IL-2
containing growth media with either glucose (MediaTech) or fatty
acids (palmitic acid, oleic acid and linoleic acid (Sigma)). Cells
were pulsed with 1 mCi/well [
3H]thymidine (MP Biomedicals),
harvested and incorporation of radioactive material was deter-
mined using a b-counter (Beckman). Fatty acids were prepared for
cell culture assays as described elsewhere [55]. For analysis of
phosphorylated STAT5A and STAT5B, 7–17 cells were pre-
treated with starvation media for 4 hours, then placed into IL-2
containing growth media supplemented with 33.3 mM glucose for
24 hours. Cells were starved for additional 4 hours +/2 glucose,
followed by treatment with 40U/ml IL-2. Cells were lysed in
TritonX Lysis Buffer, analyzed by Western blot using antibodies
against phosphorylated STAT5A/STAT5B (Tyr
694) and total
STAT5 (Cell Signaling), probed with secondary goat anti-rabbit
IgG-HRP (Southern Biotech) and developed with Super Signal
West Pico Chemiluminescence Kit (Thermo Scientific).
Epidermal cell preparation
Epidermal cells were isolated from mouse skin as described
previously [1,37] and rested at 37uC for 3–16 hours followed by
antibody staining and flow cytometric analysis. For in vitro
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epidermis and placed into culture in complete DMEM media
(Mediatech, Inc.) supplemented with 10% heat-inactivated FBS
(Omega Scientific) and stimulated overnight with pre-coated
anti-CD3e antibody at 1 mg/ml. Approximately 16 to 18 hours
after culturing, cells were treated with 5 mg/ml brefeldin A (Sigma)
for 4 hours at 37uC, isolated and stained intracellularly with
antibodies for flow cytometry. All cells were cultured at 37uC and
5% CO2.
Freshly isolated cd T cells
Epidermal cell preparations were prepared from wild-type
C57BL/6J mice as described above, and cd T cells were sorted on
a FACSAria (TSRI Flow Cytometry Lab) based on anti-Thy1.2
antibody staining to a minimum of 95% purity. Skin cd T cells
were collected into FCS, spun down and placed directly into 96
well round bottom plates in normal growth media (cRPMI with
10% FBS and 100U/ml IL-2) with baseline (11.1 mM) or elevated
(33.3 mM) glucose. Cell proliferation was based on [
3H]
thymidine incorporation as described above.
BrdU treatment in vivo
Mice were given a one time i.p. injection of 3.3 mg/ml BrdU
(Sigma) in PBS, followed by 7 days of BrdU in their drinking water
at 0.8 mg/ml. Mice were euthanized on day 8 and epidermal cells
were isolated as described above. BrdU incorporation was
detected by using the FITC BrdU Flow Kit (BD Biosciences).
Epidermal ear sheet and whole skin immunofluorescence
Epidermal sheets were isolated and stained as described
previously [1,37]. For in vitro stimulation assays, ears were removed
from control db/+ animals, separated in half and floated on
DMEM media (supplemented with 10% FBS) and treated with
10 mg/ml anti-CD3e antibody or 100 ng/ml recombinant TNFa
(R&D Systems) as indicated. After indicated incubation at 37uC,
ear sheet halves were removed, the epidermal sheet was separated
from the dermis using ammonium thiocyanate and staining was
performed. To visualize cross-sections of mouse skin, whole skin
tissue was embedded in O.C.T. compound (Tissue-Tek), and
10 mm skin sections were cut on a Leica Cryostat. Sections were
fixed with 4% paraformaldehyde for 10 minutes, and immuno-
stained with cd TCR and CD3e antibodies. DAPI was used to
counterstain the sections. Digital images were acquired (Zeiss
AxioCam HRc) and analyzed using Photoshop CS2 software
(Adobe). At least three separate experiments were performed for
each time point and a minimum of 500 cells were quantified per
experiment.
Animal dorsal and ear wounding protocols
Full-thickness biopsy punch wounds were performed on the
dorsal surface and ears of mice as previously described [1,14]. At
the indicated time after wounding, mice were euthanized and
wounds were harvested. Epidermal sheets were isolated for
analysis of cd T cell rounding at the wound site by immunoflu-
orescent microscopy. Epidermal cells were isolated using trypsin as
described above, allowed to rest three hours in the presence of
5 mg/ml brefeldin A at 37uC, and followed by intracellular
antibody staining for TNFa and/or TGFb1 expression and
analysis by flow cytometry. For anti-TNFa treatment, obese db/db
animals were randomly assigned to a treatment group, then
weighed and blood glucose determined before the start of
experiment. Mice received 1 mg/kg either anti-TNFa or IgG
control antibody (Biolegend) each day i.p. for a minimum of 4 days
total. On the final day of treatment, mice were euthanized and
full-thickness punch biopsy wounds were administered as de-
scribed above. Non-wounded skin and skin at the wound edge was
removed 24 hours post-wounding and epidermal cells were
isolated and stained for intracellular cytokine production as
described above.
Microarray analysis
Epidermal cell preparations from mice were isolated and skin cd
T cells were sorted on a FACSAria as described above. Skin cd T
cells were collected directly into TRIzol LS reagent (Invitrogen),
RNA was immediately isolated using the Qiagen RNeasy Micro
RNA Kit and submitted to the TSRI DNA Array Core. 100 ng
product was processed with GeneChip Whole Transcript Sense
Target Labeling Assay (Affymetrix) and cDNA was hybridized
overnight to the Mouse Gene 1.0ST Array (two independent data
sets for each sample). Chips were scanned using the Affymetrix
GeneChip Scanner 3000 7G with default settings and a target
intensity of 250 for scaling. Data normalization was performed
using RMA Express 1.0 with quantile normalization, median
polish and background adjustment. This data has been deposited
in NCBI’s Gene Expression Omnibus and is accessible through
GEO Series accession number GSE22196.
PCR determination of Lep and Lepr isoforms (Ob-Ra and
Ob-Rb)
RNA was isolated from primary sorted skin cd T cells or 7–17
cell lines with TRIzol reagent and transcribed into cDNA with
reverse transcriptase (Invitrogen). 1 ml cDNA was amplified using
PCR with primers directed against Ob-Ra and Ob-Rb for 35
cycles [56], leptin for 30 cycles [57] and b-actin controls [1]. A
plasmid containing leptin cDNA was kindly provided by Dr. Luc
Teyton (The Scripps Research Institute, La Jolla).
Lymph node staining
Lymph nodes were isolated from mice and pooled. Cells were
mechanically disrupted from the tissue by gently agitating between
two frosted slides in DMEM. Cells were stained for flow
cytometric analysis using antibodies listed above.
Statistic analysis
Data are presented as mean 6 SEM or mean 6 SD and
significance was determined using the t-test function of Microsoft
Excel (two-tailed).
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0011422.s001 (0.04 MB
DOC)
Figure S1 Expression of Leptin and Leptin Receptor in skin cd
T cells. RT-PCR for expression of Lep mRNA in skin cd T cells
isolated from BKS db/+ and db/db mice, or from skin cd 7-17 T
cells 61 mg/ml anti-CD3e stimulation for 2 hours or 24 hours.
Shown is Lep cDNA positive control and H2O negative control.
Expression of Lepr isoforms, Ob-Ra and Ob-Rb, mRNA was not
detected in mouse cd T cells. RT-PCR for expression of Lepr in
skin cd T cells isolated from BKS db/+ and db/db mice, or in 7–
17 skin cd T cells 61 mg/ml anti-CD3e stimulation for 2 hours or
24 hours. Shown is whole liver positive control and H2O negative
control. b-actin expression was used to control for all PCR
reactions.
Found at: doi:10.1371/journal.pone.0011422.s002 (0.34 MB TIF)
Skin cd T Cells in Obesity
PLoS ONE | www.plosone.org 14 July 2010 | Volume 5 | Issue 7 | e11422Figure S2 Fatty acids do not inhibit skin cd T cell growth.
Proliferation of skin cd 7–17 T cells in IL-2 containing growth
media supplemented with palmitic, lineolic and oleic acid between
0 and 200 mM. Each experiment was performed in duplicate, data
presented as mean 6 SD.
Found at: doi:10.1371/journal.pone.0011422.s003 (0.28 MB TIF)
Figure S3 Skin cd T cells in the db/db mouse are not
undergoing apoptosis or migration. (A) Multiparameter flow
cytometry of annexin-V/PI staining of skin cd T cells, gated on
Thy1.2+ expression, at 6-, 8- and 14-weeks of age. Numbers
indicate the percent of cd T cells. A minimum of two experiments
were performed per time point, shown is one representative
experiment. (B) Skin sections from 10- to 14-week old BKS db/+
and db/db mice were immunostained with cd TCR (red) and dapi
(blue). Three separate experiments were performed with similar
results. Magnification is 6200, bar represents 0.05 mm. (C) cd T
cell populations in skin-draining lymph nodes isolated from 10- to
14-week old BKS db/+ and db/db animals. In the upper plots,
live cells were gated on Thy1.2+ and Vc3+, exclusive markers for
skin-specific cd T cells. In the lower plots, cells were gated on cd
TCR+ and CD3+ T cells to visualize the peripheral cd T cell
population. Numbers indicate percent cd T cells. Data are
representative of two independent experiments.
Found at: doi:10.1371/journal.pone.0011422.s004 (1.08 MB TIF)
Figure S4 Skin cd T cell activation marker and cd TCR
expression is not altered by hyperglycemia. (A) Multiparameter
flow cytometry of CD69, CD25 and CD103 on the cell surface of
cd T cells isolated from BKS db/+ and db/db in mice at 6-weeks
of age. Numbers in the top right corners indicate percent of cd T
cells. (B) cd TCR expression on cd T cells isolated from BKS db/+
(solid line) and db/db (shaded gray) at 6-weeks of age. Dotted lines
represent unstained controls. Epidermal cells were gated on live
Thy1.2+ to distinguish cd T cells. A minimum of three
experiments were performed per age, shown is one representative
experiment for each, the same number of events is presented for
each dot plot.
Found at: doi:10.1371/journal.pone.0011422.s005 (0.42 MB TIF)
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